Liquidia (LQDA) Other Accumulated Expenses (2019 - 2026)

Liquidia's (LQDA) quarterly Other Accumulated Expenses came in at $11.3 million in Q1 2026, up 119.73% year-on-year from $5.2 million in Q1 2025, and up 34.83% quarter-over-quarter from $8.4 million in Q4 2025.

Liquidia (LQDA) Other Accumulated Expenses (2019 - 2026) Analysis & Trends

Liquidia's Other Accumulated Expenses history runs 8 years deep, the most recent figure standing at $11.3 million for Q1 2026.

  • On a quarterly basis, Other Accumulated Expenses rose 119.73% year-over-year to $11.3 million in Q1 2026; TTM through Mar 2026 was $11.3 million, a 119.73% increase from a year earlier, with the FY2025 full-year figure at $8.4 million, up 96.65% from the prior year.
  • Other Accumulated Expenses grew to $11.3 million in Q1 2026 per LQDA's latest filing, from $8.4 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $11.3 million in Q1 2026 and bottomed at $903000.0 in Q4 2022.
  • The 5-year median for Other Accumulated Expenses is $4.3 million (2024), against an average of $4.3 million.
  • Across the five-year window, Other Accumulated Expenses plunged 73.47% in 2023 and jumped 304.44% in 2024, its largest moves.
  • Year by year, Other Accumulated Expenses stood at $903000.0 in 2022, then surged by 116.39% to $2.0 million in 2023, then soared by 118.63% to $4.3 million in 2024, then surged by 96.65% to $8.4 million in 2025, then surged by 34.83% to $11.3 million in 2026.
  • Per Business Quant, the three latest LQDA Other Accumulated Expenses figures stand at $11.3 million (Q1 2026), $8.4 million (Q4 2025), and $7.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 88.88 Bn 87.01 Bn -
2 Teva Pharmaceutical Industries 35.92 Bn 32.18 Bn 1.97 Bn
3 Zoetis 32.31 Bn 30.37 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn
5 United Therapeutics 23.07 Bn 20.91 Bn 648.10 Mn
6 RedHill Biopharma 20.53 Bn 20.53 Bn -
7 Viatris 20.27 Bn 18.47 Bn 1.16 Bn
8 Neurocrine Biosciences 17.92 Bn 16.61 Bn 800.70 Mn
9 Elanco Animal Health 12.61 Bn 12.18 Bn 785.00 Mn
10 Liquidia 7.82 Bn 7.60 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.33 Mn
Dec 31, 2025 8.40 Mn
Sep 30, 2025 7.47 Mn
Jun 30, 2025 10.01 Mn
Mar 31, 2025 5.16 Mn
Dec 31, 2024 4.27 Mn
Sep 30, 2024 4.25 Mn
Jun 30, 2024 2.66 Mn
Mar 31, 2024 4.64 Mn
Dec 31, 2023 1.95 Mn
Sep 30, 2023 2.38 Mn
Jun 30, 2023 1.40 Mn
Mar 31, 2023 1.15 Mn
Dec 31, 2022 903,000.00
Sep 30, 2022 1.31 Mn
Jun 30, 2022 1.25 Mn
Mar 31, 2022 4.33 Mn
Dec 31, 2021 1.67 Mn
Sep 30, 2021 2.32 Mn
Jun 30, 2021 1.76 Mn